Epoetin Alfa Hexal Europska Unija - hrvatski - EMA (European Medicines Agency)

epoetin alfa hexal

hexal ag - epoetin alfa - anemia; kidney failure, chronic; cancer - antianemijski pripravci - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients: , treatment of anaemia associated with chronic renal failure in paediatric and adult patients on haemodialysis and adult patients on peritoneal dialysis;, treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis. liječenje anemije i smanjenje potrebe transfuzije krvi kod odraslih pacijenata koji primaju kemoterapiju za uglednih tumora maligni limfom ili multiple myeloma, kao i na rizik трансфузии оцениваемым opće stanje pacijenta (e. stanje kardiovaskularnog sustava, već postojeće anemije u početku kemoterapije).

Lamzede Europska Unija - hrvatski - EMA (European Medicines Agency)

lamzede

chiesi farmaceutici s.p.a. - velmanase alfa - alfa-mannosidosis - drugi gastrointestinalni trakt i metabolizam, lijekovi, - liječenje ne neurološke manifestacije kod bolesnika s blagom do umjereno alfa-mannosidosis.

ROWACHOL 13.6 mg/1 kapsula+ 3.4 mg/1 kapsula+ 5 mg/1 kapsula+ 2 mg/1 kapsula+ 6 mg/1 kapsula+ 32 mg/1 kapsula+ 5 mg/1 kapsula že Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

rowachol 13.6 mg/1 kapsula+ 3.4 mg/1 kapsula+ 5 mg/1 kapsula+ 2 mg/1 kapsula+ 6 mg/1 kapsula+ 32 mg/1 kapsula+ 5 mg/1 kapsula že

medical intertrade d.o.o. sarajevo - alfa pinen, beta pinen, borneol, levomentol, kamfen, menton - želučanootporna kapsula, meka - 13.6 mg/1 kapsula+ 3.4 mg/1 kapsula+ 5 mg/1 kapsula+ 2 mg/1 kapsula+ 6 mg/1 kapsula+ 32 mg/1 kapsula+ 5 mg/1 kapsula - 1 želučanootporna kapsula, meka sadrži: 13,6 mg alfa pinen, 3,4 mg beta pinen, 32 mg levomentol, 6 mg menton, 5 mg borneol, 5 mg kamfen, 2 mg cineol

Bemfola Europska Unija - hrvatski - EMA (European Medicines Agency)

bemfola

gedeon richter plc. - follitropin alfa - anovulacija - spolni hormoni i modulatori genitalnog sustava, - in adult women:anovulation (including polycystic ovarian disease, pcod) in women who have been unresponsive to treatment with clomiphene citrate;stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (art) such as in vitro fertilisation (ivf), gamete intra-fallopian transfer (gift) and zygote intra-fallopian transfer (zift);follitropin alfa in association with a luteinising hormone (lh) preparation is recommended for the stimulation of follicular development in women with severe lh and fsh deficiency. u kliničkim istraživanjima kod ovih pacijenata su identificirani endogene razina lh u serumu < 1. 2 iu / l. in adult men:follitropin alfa is indicated for the stimulation of spermatogenesis in men who have congenital or acquired hypogonadotrophic hypogonadism with concomitant human chorionic gonadotrophin (hcg) therapy.

Nexviadyme Europska Unija - hrvatski - EMA (European Medicines Agency)

nexviadyme

sanofi b.v. - avalglucosidase alfa - vrsta ii za skladištenje glikogena - drugi gastrointestinalni trakt i metabolizam, lijekovi, - nexviadyme (avalglucosidase alfa) is indicated for long-term enzyme replacement therapy for the treatment of patients with pompe disease (acid α-glucosidase deficiency).

Pombiliti Europska Unija - hrvatski - EMA (European Medicines Agency)

pombiliti

amicus therapeutics europe limited - cipaglucosidase alfa - vrsta ii za skladištenje glikogena - drugi gastrointestinalni trakt i metabolizam, lijekovi, - pombiliti (cipaglucosidase alfa) is a long-term enzyme replacement therapy used in combination with the enzyme stabiliser miglustat for the treatment of adults with late-onset pompe disease (acid α-glucosidase [gaa] deficiency).